Mpact Cup Performance After Total Hip Arthroplasty

Prospective, Multicentric, Non-controlled, Non-randomized Clinical Survey to Evaluate Mpact Cup Performance After Total Hip Arthroplasty

Status

Suspended

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02846636

Enrollment

100

Registered

2016-07-27

Start date

2014-08-31

Completion date

2029-04-30

Last updated

2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Replacement

Brief summary

The main objective of this study is to evaluate the 10 year performances of Mpact cup in total hip arthroplasty.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients requiring a total hip replacement who meets the standard indications for use for Medacta implants * patients who accept to participate in the study * patients who signed the consent form for the treatment of personal data

Exclusion criteria

* patients presenting conditions identified as contraindication for Medacta implants * revision surgeries

Design outcomes

Primary

Measure	Time frame
implant survival trough Kaplan-Meier curve	10 years

Secondary

Measure	Time frame
hip function with Harris Hip Score	preop, 3/6 months, 1, 3, 5, 7, 10 years
record of adverse events	intraop, 3/6 months, 1, 3, 5, 7, 10 years
implant stability trough assessment of presence of radiolucencies	3/6 months, 1, 3, 5, 7, 10 years

Countries

France

Outcome results